MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 42 filers reported holding MERSANA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $433,000 | +56.3% | 107,072 | +102.8% | 0.03% | +130.8% |
| Q1 2019 | $277,000 | +38.5% | 52,800 | +7.3% | 0.01% | -7.1% |
| Q4 2018 | $200,000 | -49.1% | 49,200 | +97.4% | 0.01% | -44.0% |
| Q1 2018 | $393,000 | +84.5% | 24,929 | +91.8% | 0.02% | +127.3% |
| Q4 2017 | $213,000 | -34.1% | 13,000 | -30.4% | 0.01% | -35.3% |
| Q3 2017 | $323,000 | – | 18,688 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |